Literature DB >> 9620352

Transcatheter arterial embolization for advanced hepatocellular carcinoma: the controversy continues.

S Okada.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9620352     DOI： 10.1002/hep.510270639

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  9 in total

1.  Pathological complete remission of advanced hepatocellular carcinoma with main portal vein tumor thrombosis by hepatic arterial infusion chemotherapy.

Authors:  Yong Gil Kim; Jong Ryul Eun; Tae Nyeun Kim; Heon Ju Lee; Jae Woon Kim; Jay Chun Chang; Sung Su Yun; Joon Hyuk Choi
Journal:  Gut Liver       Date:  2010-06-16       Impact factor: 4.519

2.  An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging features.

Authors:  Xin Li; Chuan-Sheng Zheng; Gan-Sheng Feng; Chen-Kai Zhuo; Jun-Gong Zhao; Xi Liu
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

3.  The effect of different interventional treatment on P-Glycoprotein in different histopathological types and grades of primary hepatocellular carcinoma.

Authors:  E Xiao; G Hu; P Liu; D Hu; S Liu; C Hao
Journal:  J Tongji Med Univ       Date:  2000

4.  Transarterial chemoembolization with Doxorubicin-eluting microspheres for inoperable hepatocellular carcinoma.

Authors:  Sanjeeva P Kalva; Shams I Iqbal; Kalpana Yeddula; Lawrence S Blaszkowsky; Adnan Akbar; Stephan Wicky; Andrew X Zhu
Journal:  Gastrointest Cancer Res       Date:  2011-01

Review 5.  Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; Flora Hau-Fung Tsang; John Wong
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

6.  Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level.

Authors:  Xin Li; Gan-Sheng Feng; Chuan-Sheng Zheng; Chen-Kai Zhuo; Xi Liu
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

7.  Clinical significance and risk factors of postembolization fever in patients with hepatocellular carcinoma.

Authors:  Chung Hwan Jun; Ho Seok Ki; Hoon Ki Lee; Kang Jin Park; Seon Young Park; Sung Bum Cho; Chang Hwan Park; Young Eun Joo; Hyun Soo Kim; Sung Kyu Choi; Jong Sun Rew
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

8.  Postoperative adjuvant arterial chemoembolization improves the survival of hepatitis B virus-related hepatocellular carcinoma: a retrospective control study.

Authors:  F Li; Z Guo; Y Zhang; H Wang; X Zhang; T Si; H Yu; L Qi
Journal:  Ir J Med Sci       Date:  2014-06-28       Impact factor: 1.568

9.  An Imaging and Histological Study on Intrahepatic Microvascular Passage of Contrast Materials in Rat Liver.

Authors:  Qian Xia; Yuanbo Feng; Ting Yin; Yewei Liu; Guozhi Zhang; Jianjun Liu; Linjun Tong; Robin Willemyns; Jie Yu; Raymond Oyen; Gang Huang; Yicheng Ni
Journal:  Biomed Res Int       Date:  2017-02-15       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.